MDWD News and Press, MediWound Ltd. From 11/05/25

MediWound to Report Third Quarter 2025 Financial Results Conference call and webcast scheduled for Thursday, November 20 at 8:30 a.m. Eastern Time YAVNE, Israel, November 5, 2025 -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a global leader in next-generation e...

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid ® Newly commissioned facility marks a significant development toward a sixfold production capacity increase ahead of full operational readiness by year-end 2025 YAVNE, I...

2025-09-29 08:57:02 ET More on MediWound MediWound Is A Buy Opportunity On The Dip Seeking Alpha’s Quant Rating on MediWound Historical earnings data for MediWound Read the full article on Seeking Alpha For further details see: MediWound an...

MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares YAVNE, Israel, September 29, 2025 -- MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced th...

MediWound Expands Global Reach with Marketing Approval of NexoBrid ® in Australia TGA Approves NexoBrid ® for Adults and Children; Manufacturing Readiness Positions MediWound for 2025 Launch and Asia-Pacific Expansion YAVNE, Israel, September 25, ...

MediWound’s NexoBrid ® to be Highlighted in 36 Scientific Presentations at the 21 st European Burns Association Congress YAVNE, Israel, September 2, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue re...

2025-09-02 05:42:32 ET Opportunity is Knocking MediWound Ltd. ( MDWD ) is a stock that proves the adage that obscurity is the worst place to be. Investors are often attracted to biomed startups. MDWD shares topped $41 each in 2021. Interest waned as R&D and...

2025-08-14 13:31:53 ET MediWound Ltd. (MDWD) Q2 2025 Earnings Conference Call August 14 2025, 08:30 AM ET Company Participants Barry J. Wolfenson - Executive Vice President of Strategy & Corporate Development... Read the full article on Seeking Alpha For ...

2025-08-14 07:07:11 ET More on MediWound MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript MediWound Ltd.: Undervalued High-Growth Potential MediWound Q2 2025 Earnings Preview MediWound Q1 2025 Earnings Preview Seeking Alpha’s Quant Rating...

Century Therapeutics Inc. (IPSC) is expected to report $-0.38 for Q2 2025 Birchtech Corp Com (BCHT) is expected to report for Q2 2025 Cellectar Biosciences Inc. (CLRB) is expected to report $-3.6 for Q2 2025 Acuren Corporation (TIC) is expected to report for quarter end 2025-06-30 ...